REVIVE THERAPEUTICS LTD COM's ticker is RVVTF and the CUSIP is 761516103. A total of 5 filers reported holding REVIVE THERAPEUTICS LTD COM in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $5,000 | +150.0% | 15,510 | +0.1% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 15,500 | -0.1% | 0.00% | – |
| Q4 2021 | $4,000 | -33.3% | 15,510 | 0.0% | 0.00% | – |
| Q3 2021 | $6,000 | -14.3% | 15,510 | 0.0% | 0.00% | – |
| Q2 2021 | $7,000 | +16.7% | 15,510 | +0.1% | 0.00% | – |
| Q1 2021 | $6,000 | +500.0% | 15,500 | +933.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 5,000 | $1,000 | 0.00% |
| GOFEN & GLOSSBERG LLC /IL/ | 100,000 | $14,000 | 0.00% |
| American Research & Management Co. | 1,000 | $0 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 15,500 | $2,000 | 0.00% |